Aug 28 2024
A new study published in the peer-reviewed journal Cannabis and Cannabinoid Research and available online through the National Institutes of Health found that when it comes to COVID-19, “Cannabis users had better outcomes and mortality compared with non-users”. The research, which utilized data from the National Inpatient Sample Database, sought to evaluate the impact of …
Aug 28 2024
A recent international study has found that cannabidiol (CBD) may offer significant relief for patients suffering from drug-resistant epilepsy associated with glycosylphosphatidylinositol-anchored protein deficiencies (GPI-ADs). Published this month in the peer-reviewed journal Cannabis and Cannabinoid Research, the study was conducted by a team of researchers from Italy, Denmark, Brazil, Germany, and the United States. The …
Aug 26 2024
An NFL-funded study published in the journal Sports Medicine reveals the growing role of marijuana as a therapeutic tool for athletes, highlighting its potential to address issues like pain, anxiety and brain injuries, while also acknowledging the complications and lack of knowledge caused by strict laws and regulations. “The increasing legalization of Cannabis sativa plant …
Aug 26 2024
The results of a new study published in the peer-reviewed journal Naunyn-Schmiedeberg’s Archives of Pharmacology “underscores CBD as a promising protective agent against sepsis-induced renal damage.” The research, conducted by teams from Suleyman Demirel University and Burdur Mehmet Akif Ersoy University in Turkey, explored how CBD could mitigate the harmful effects of lipopolysaccharide (LPS)-induced kidney …
Aug 26 2024
A new study published in the journal BMJ Mental Health reveals promising insights into the effects of cannabidiol (CBD) on key biomarkers associated with schizophrenia. Conducted by researchers from Germany’s Central Institute of Mental Health, Goethe University Frankfurt, the University of Goettingen, and Australia’s University of Sydney, the randomized clinical trial explored how varying doses …
Aug 23 2024
A new study published this week by The British Medical Journal and the US National Institute of Health reveals that high-dose psilocybin may offer benefits in treating depression. Conducted by a team of researchers from multiple hospitals and universities in Taiwan, the study systematically reviewed and analyzed the performance of various psychedelics, including LSD and MDMA, …
Aug 23 2024
A new study published in Forensic Science International reveals that while alcohol and benzodiazepines have a clear and significant impact on driver impairment as their blood concentrations rise, the effects of THC are much less consistent and harder to predict, calling into question per se THC driving limits. The research, which examined over 15,000 cases …
Aug 23 2024
A new study published in the journal Frontiers in Immunology explores the potential role of cannabinoids in treating triple-negative breast cancer, a particularly aggressive form of breast cancer that accounts for 10-20% of all cases. Conducted by researchers from the University of Ljubljana and the Institute of Oncology Ljubljana in Slovenia, the study examines how …
Aug 22 2024
According to researchers at the University of Bonn and the Hebrew University of Jerusalem, the long-term, low-dose administration of tetrahydrocannabinol (THC) can reverse aging processes in the brain and may have broader anti-aging effects. The study, recently published in the journal ACS Pharmacology & Translational Science, sheds light on the complex role of the protein …
Aug 22 2024
Researchers at the University of Colorado Boulder have uncovered a potential breakthrough in autism prevention. A new study, published in the journal Brain, Behavior, & Immunity – Health and also published online by the National Institute of Health, found that administering broad-spectrum cannabidiol (CBD) oil during pregnancy may prevent the development of autism-like behaviors in …
